Patents by Inventor Ferdinando FIORINO

Ferdinando FIORINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250090551
    Abstract: The present invention relates to budesonide 21-phosphate sodium salt for use as anti-inflammatory agent or as anti-asthmatic agent. The invention further relates to pharmaceutical compositions containing the same.
    Type: Application
    Filed: July 20, 2022
    Publication date: March 20, 2025
    Inventors: Giuseppe CALIENDO, Giuseppe CIRINO, Ferdinando FIORINO, Francesco FRECENTESE, Marcelo Nicolas MUSCARĂ€, Elisa PERISSUTTI, Antonio PETTI, Fiorentina ROVIEZZO, Vincenzo SANTAGADA, Beatrice SEVERINO, Elisa MAGLI
  • Publication number: 20240343757
    Abstract: The present invention relates to a new process for the preparation of budesonide 21-phosphate and its disodium salt.
    Type: Application
    Filed: July 20, 2022
    Publication date: October 17, 2024
    Inventors: Giuseppe CALIENDO, Angela CORVINO, Ferdinando FIORINO, Francesco FRECENTESE, Elisa MAGLI, Elisa PERISSUTTI, Antonio PETTI, Vincenzo SANTAGADA, Beatrice SEVERINO
  • Publication number: 20230115869
    Abstract: The present invention relates to salts of budesonide 21-phosphate with ?2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.
    Type: Application
    Filed: March 25, 2021
    Publication date: April 13, 2023
    Inventors: Giuseppe CALIENDO, Giuseppe CIRINO, Ferdinando FIORINO, Francesco FRECENTESE, Marcelo Nicolas MUSCARĂ€, Elisa PERISSUTTI, Antonio PETTI, Fiorentina ROVIEZZO, Vincenzo SANTAGADA, Beatrice SEVERINO, Elisa MAGLI
  • Publication number: 20220251136
    Abstract: The present invention relates to esters of Montelukast with corticosteroids, preferably with des-ciclesonide, triamcinolone, budesonide or flunisolide, pharmaceutical compositions containing the same and the use thereof in the treatment of several respiratory tract diseases, especially asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The invention further relates to the process for preparing said esters.
    Type: Application
    Filed: August 4, 2020
    Publication date: August 11, 2022
    Inventors: Giuseppe CALIENDO, Giuseppe CIRINO, Ferdinando FIORINO, Francesco FRECENTESE, Marcelo Nicolas MUSCARA', Elisa PERISSUTTI, Antonio PETTI, Vincenzo SANTAGADA, Beatrice SEVERINO, Fiorentina ROVIEZZO
  • Publication number: 20220218690
    Abstract: The present invention relates to salts of Montelukast with ?2 adrenergic agonists, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.
    Type: Application
    Filed: June 5, 2020
    Publication date: July 14, 2022
    Inventors: Giuseppe CALIENDO, Giuseppe CIRINO, Ferdinando FIORINO, Francesco FRECENTESE, Marcelo Nicolas MUSCARA', Elisa PERISSUTTI, Antonio PETTI, Fiorentina ROVIEZZO, Vincenzo SANTAGADA, Beatrice SEVERINO